Despite being driven by germline mutations in functionally related genes,BRCA1, BRCA2, and PALB2mutated breast cancers constitute a heterogeneous group of tumors at theimmunohistochemical and molecular level (Table1). The gene discussed is BRCA1; the disease is breast cancer.